# Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product

> **NCT00291382** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 150 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salmeterol/fluticasone propionate combination

## Key facts

- **NCT ID:** NCT00291382
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291382, "Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00291382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*